Literature DB >> 25964986

Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP.

John C McGrath1, Elliot Lilley2.   

Abstract

The ARRIVE guidelines have been implemented in BJP for 4 years with the aim of increasing transparency in reporting experiments involving animals. BJP has assessed our success in implementing them and concluded that we could do better. This editorial discusses the issues and explains how we are changing our requirements for authors to report their findings in experiments involving animals. This is one of a series of editorials discussing updates to the BJP Instructions to Authors.
© 2015 The British Pharmacological Society.

Mesh：

Year:  2015        PMID： 25964986      PMCID： PMC4500358          DOI： 10.1111/bph.12955

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


  8 in total

1.  Guidelines for reporting experiments involving animals: the ARRIVE guidelines.

Authors:  J C McGrath; G B Drummond; E M McLachlan; C Kilkenny; C L Wainwright
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Animal research: reporting in vivo experiments: the ARRIVE guidelines.

Authors:  Carol Kilkenny; William Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Statistics: all together now, one step at a time.

Authors:  Gordon B Drummond; David J Paterson; P McLoughlin; John C McGrath
Journal:  Br J Nutr       Date:  2011-05       Impact factor: 3.718

4.  Transparency in Research involving Animals: The Basel Declaration and new principles for reporting research in BJP manuscripts.

Authors:  John C McGrath; Elspeth M McLachlan; Rolf Zeller
Journal:  Br J Pharmacol       Date:  2015-05       Impact factor: 8.739

5.  Experimental design and analysis and their reporting: new guidance for publication in BJP.

Authors:  Michael J Curtis; Richard A Bond; Domenico Spina; Amrita Ahluwalia; Stephen P A Alexander; Mark A Giembycz; Annette Gilchrist; Daniel Hoyer; Paul A Insel; Angelo A Izzo; Andrew J Lawrence; David J MacEwan; Lawrence D F Moon; Sue Wonnacott; Arthur H Weston; John C McGrath
Journal:  Br J Pharmacol       Date:  2015-07       Impact factor: 8.739

6.  CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials.

Authors:  Kenneth F Schulz; Douglas G Altman; David Moher
Journal:  BMJ       Date:  2010-03-23

7.  Survey of the quality of experimental design, statistical analysis and reporting of research using animals.

Authors:  Carol Kilkenny; Nick Parsons; Ed Kadyszewski; Michael F W Festing; Innes C Cuthill; Derek Fry; Jane Hutton; Douglas G Altman
Journal:  PLoS One       Date:  2009-11-30       Impact factor: 3.240

8.  Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studies.

Authors:  David Baker; Katie Lidster; Ana Sottomayor; Sandra Amor
Journal:  PLoS Biol       Date:  2014-01-07       Impact factor: 8.029
  8 in total
  769 in total

1.  Metabolic profiling of murine plasma reveals eicosapentaenoic acid metabolites protecting against endothelial activation and atherosclerosis.

Authors:  Yajin Liu; Xuan Fang; Xu Zhang; Jing Huang; Jinlong He; Liyuan Peng; Chenji Ye; Yingmei Wang; Fengxia Xue; Ding Ai; Dan Li; Yi Zhu
Journal:  Br J Pharmacol       Date:  2017-09-05       Impact factor: 8.739

2.  Effects of centrally administered endocannabinoids and opioids on orofacial pain perception in rats.

Authors:  Marek Zubrzycki; Anna Janecka; Andreas Liebold; Mechthild Ziegler; Maria Zubrzycka
Journal:  Br J Pharmacol       Date:  2017-08-30       Impact factor: 8.739

3.  Knockdown of the transcript of ERK in the brain modulates hypothalamic neuropeptide-mediated appetite control in amphetamine-treated rats.

Authors:  Ching-Han Yu; Yih-Shou Hsieh; Pei-Ni Chen; Jeng-Rung Chen; Dong-Yih Kuo
Journal:  Br J Pharmacol       Date:  2018-01-11       Impact factor: 8.739

4.  VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation through PPARγ- and CB2 receptor-dependent pathways.

Authors:  Carmen Del Rio; Irene Cantarero; Belén Palomares; María Gómez-Cañas; Javier Fernández-Ruiz; Carolina Pavicic; Adela García-Martín; Maria Luz Bellido; Rafaela Ortega-Castro; Carlos Pérez-Sánchez; Chary López-Pedrera; Giovanni Appendino; Marco A Calzado; Eduardo Muñoz
Journal:  Br J Pharmacol       Date:  2018-08-23       Impact factor: 8.739

5.  Protective effects of dioscin against cisplatin-induced nephrotoxicity via the microRNA-34a/sirtuin 1 signalling pathway.

Authors:  Yimeng Zhang; Xufeng Tao; Lianhong Yin; Lina Xu; Youwei Xu; Yan Qi; Xu Han; Shasha Song; Yanyan Zhao; Yuan Lin; Kexin Liu; Jinyong Peng
Journal:  Br J Pharmacol       Date:  2017-07-05       Impact factor: 8.739

6.  Central amygdala relaxin-3/relaxin family peptide receptor 3 signalling modulates alcohol seeking in rats.

Authors:  Leigh C Walker; Hanna E Kastman; Elena V Krstew; Andrew L Gundlach; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2017-08-23       Impact factor: 8.739

7.  Functional interplay between liver X receptor and AMP-activated protein kinase α inhibits atherosclerosis in apolipoprotein E-deficient mice - a new anti-atherogenic strategy.

Authors:  Chuanrui Ma; Wenwen Zhang; Xiaoxiao Yang; Ying Liu; Lipei Liu; Ke Feng; Xiaomeng Zhang; Shu Yang; Lei Sun; Miao Yu; Jie Yang; Xiaoju Li; Wenquan Hu; Robert Q Miao; Yan Zhu; Luyuan Li; Jihong Han; Yuanli Chen; Yajun Duan
Journal:  Br J Pharmacol       Date:  2018-03-23       Impact factor: 8.739

8.  JQ1, a bromodomain inhibitor, suppresses Th17 effectors by blocking p300-mediated acetylation of RORγt.

Authors:  Xiunan Wang; Yan Yang; Dandan Ren; Yuanyuan Xia; Wenguang He; Qingsi Wu; Junling Zhang; Miao Liu; Yinan Du; Cuiping Ren; Bin Li; Jijia Shen; Yuxia Zhang
Journal:  Br J Pharmacol       Date:  2020-03-23       Impact factor: 8.739

9.  Implication of in vivo circulating fibrocytes ablation in experimental pulmonary hypertension murine model.

Authors:  Vandana S Nikam; Sandeep Nikam; Akyl Sydykov; Katrin Ahlbrecht; Rory E Morty; Werner Seeger; Robert Voswinckel
Journal:  Br J Pharmacol       Date:  2020-04-12       Impact factor: 8.739

10.  Role of the nicotinic acetylcholine receptor α3 subtype in vascular inflammation.

Authors:  Cui Yang; Zhengtao Li; Saimei Yan; Yonghui He; Rong Dai; George Pek-Heng Leung; Shitian Pan; Jinyan Yang; Rong Yan; Guanhua Du
Journal:  Br J Pharmacol       Date:  2016-09-29       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.